NextCure, Inc. (NXTC) Misses Q1 EPS by 17c

NextCure, Inc. (NASDAQ: NXTC) reported Q1 EPS of ($0.61), $0.17 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on NextCure, Inc. (NXTC) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand